Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wave Life Sciences (WVE) Capital Leases: 2015-2018

Historic Capital Leases for Wave Life Sciences (WVE) over the last 4 years, with Dec 2018 value amounting to $9.2 million.

  • Wave Life Sciences' Capital Leases rose 198.87% to $9.2 million in Q4 2018 from the same period last year, while for Dec 2018 it was $9.2 million, marking a year-over-year increase of 198.87%. This contributed to the annual value of $9.2 million for FY2018, which is 198.87% up from last year.
  • Per Wave Life Sciences' latest filing, its Capital Leases stood at $9.2 million for FY2018, which was up 198.87% from $3.1 million recorded in FY2017.
  • In the past 5 years, Wave Life Sciences' Capital Leases registered a high of $9.2 million during FY2018, and its lowest value of $78,000 during FY2015.
  • Over the past 3 years, Wave Life Sciences' median Capital Leases value was $3.1 million (recorded in 2017), while the average stood at $4.2 million.
  • Data for Wave Life Sciences' Capital Leases shows a peak YoY skyrocketed of 2,567.24% (in 2017) over the last 5 years.
  • Over the past 4 years, Wave Life Sciences' Capital Leases (Yearly) stood at $78,000 in 2015, then soared by 48.72% to $116,000 in 2016, then surged by 2,567.24% to $3.1 million in 2017, then skyrocketed by 198.87% to $9.2 million in 2018.